|
1. Biologie
|
|
|
|
4.5 Dép., diag. & prono. - Colorectal
|
|
|
|
5. Traitements
|
|
|
|
|
5.12.4 Immunothérapies - Essais
|
|
|
|
5.12.5 Immunothérapies - Pharma
|
|
|
|
5.2 Pharma
|
|
|
|
5.2.3 Pharma - économie
|
|
|
|
|
|
5.3 Traitements - FDA, EMA, NICE...
|
|
|
|
5.3.4 Traitements - AMM (FDA, EMA)
|
|
|
|
6.1 Observation
|
|
|
|
6.11 Patients
|
|
|
|
6.12 Ethique
|
|
|
Genes, cells, and biobanks: Yes, there’s still a consent problem [PLoS Biology]
|
|
|
|
|
|
From
a research perspective, the interest in biobanking continues to
intensify. Governments and industry have invested heavily in biobanks,
as exemplified by initiatives like the United Kingdom Biobank and United
States' Precision Medicine Initiative. But despite this enthusiasm,
many profound legal and ethical challenges remain unresolved.
|
|
|
|
|
|
|
6.7.1 Bioinformatique
|
|
|
|
|
6.9 Controverses
|
|
|